ABBV vs UHS
By Alex · Tickerpine
AbbVie Inc. vs Universal Health Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | UHS |
|---|---|---|
| Price | $295.03 | $194.07 |
| Market cap | $521.50B | $11.19B |
| P/E ratio | 50.7 | 8.1 |
| ROE | — | 19.74% |
| Profit margin | 15.67% | 7.96% |
| Revenue growth | 10.30% | 5.30% |
| Dividend yield | 2.35% | 0.41% |
| Beta | 0.19 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs UHS in plain English
- ABBV is the bigger company — about 46.6× the market cap of UHS.
- UHS is cheaper on earnings (P/E 8.1 vs 50.7).
- ABBV is growing revenue faster (10% vs 5%).
- ABBV has the higher dividend yield (2.35% vs 0.41%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
UHS return calculator
See what $1,000 in Universal Health Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.